219 related articles for article (PubMed ID: 32717063)
1. Gene expression profiling of hypertrophic cardiomyocytes identifies new players in pathological remodelling.
Vigil-Garcia M; Demkes CJ; Eding JEC; Versteeg D; de Ruiter H; Perini I; Kooijman L; Gladka MM; Asselbergs FW; Vink A; Harakalova M; Bossu A; van Veen TAB; Boogerd CJ; van Rooij E
Cardiovasc Res; 2021 May; 117(6):1532-1545. PubMed ID: 32717063
[TBL] [Abstract][Full Text] [Related]
2. Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy.
Cañes L; Martí-Pàmies I; Ballester-Servera C; Herraiz-Martínez A; Alonso J; Galán M; Nistal JF; Muniesa P; Osada J; Hove-Madsen L; Rodríguez C; Martínez-González J
Clin Sci (Lond); 2020 Feb; 134(3):359-377. PubMed ID: 31985010
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II type-1 receptor activation in the adult heart causes blood pressure-independent hypertrophy and cardiac dysfunction.
Ainscough JF; Drinkhill MJ; Sedo A; Turner NA; Brooke DA; Balmforth AJ; Ball SG
Cardiovasc Res; 2009 Feb; 81(3):592-600. PubMed ID: 18703536
[TBL] [Abstract][Full Text] [Related]
4. A state of reversible compensated ventricular dysfunction precedes pathological remodelling in response to cardiomyocyte-specific activity of angiotensin II type-1 receptor in mice.
Frentzou GA; Drinkhill MJ; Turner NA; Ball SG; Ainscough JF
Dis Model Mech; 2015 Aug; 8(8):783-94. PubMed ID: 26092119
[TBL] [Abstract][Full Text] [Related]
5. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling.
Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F
Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115
[TBL] [Abstract][Full Text] [Related]
7. NF-kappaB activation is required for adaptive cardiac hypertrophy.
Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of Cardiomyocyte Hypertrophy via Depletion Myh7 using CASAAV.
Yue P; Xia S; Wu G; Liu L; Zhou K; Liao H; Li J; Zheng X; Guo Y; Hua Y; Zhang D; Li Y
Cardiovasc Toxicol; 2021 Mar; 21(3):255-264. PubMed ID: 33098074
[TBL] [Abstract][Full Text] [Related]
9. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27b-3p down-regulates FGF1 and aggravates pathological cardiac remodelling.
Li G; Shao Y; Guo HC; Zhi Y; Qiao B; Ma K; Du J; Lai YQ; Li Y
Cardiovasc Res; 2022 Jul; 118(9):2139-2151. PubMed ID: 34358309
[TBL] [Abstract][Full Text] [Related]
11. Single-Cell Reconstruction of Progression Trajectory Reveals Intervention Principles in Pathological Cardiac Hypertrophy.
Ren Z; Yu P; Li D; Li Z; Liao Y; Wang Y; Zhou B; Wang L
Circulation; 2020 May; 141(21):1704-1719. PubMed ID: 32098504
[TBL] [Abstract][Full Text] [Related]
12. Targeted deletion of ERK2 in cardiomyocytes attenuates hypertrophic response but provokes pathological stress induced cardiac dysfunction.
Ulm S; Liu W; Zi M; Tsui H; Chowdhury SK; Endo S; Satoh Y; Prehar S; Wang R; Cartwright EJ; Wang X
J Mol Cell Cardiol; 2014 Jul; 72(100):104-16. PubMed ID: 24631771
[TBL] [Abstract][Full Text] [Related]
13. GDF11 Attenuated ANG II-Induced Hypertrophic Cardiomyopathy and Expression of ANP, BNP and Beta-MHC Through Down- Regulating CCL11 in Mice.
Zhang C; Wang Y; Ge Z; Lin J; Liu J; Yuan X; Lin Z
Curr Mol Med; 2018; 18(10):661-671. PubMed ID: 30714521
[TBL] [Abstract][Full Text] [Related]
14. SRF-dependent gene expression in isolated cardiomyocytes: regulation of genes involved in cardiac hypertrophy.
Nelson TJ; Balza R; Xiao Q; Misra RP
J Mol Cell Cardiol; 2005 Sep; 39(3):479-89. PubMed ID: 15950986
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-22 downregulation by atorvastatin in a mouse model of cardiac hypertrophy: a new mechanism for antihypertrophic intervention.
Tu Y; Wan L; Bu L; Zhao D; Dong D; Huang T; Cheng Z; Shen B
Cell Physiol Biochem; 2013; 31(6):997-1008. PubMed ID: 23860036
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-375-3p inhibitor suppresses angiotensin II-induced cardiomyocyte hypertrophy by promoting lactate dehydrogenase B expression.
Feng H; Wu J; Chen P; Wang J; Deng Y; Zhu G; Xian J; Huang L; Ouyang W
J Cell Physiol; 2019 Aug; 234(8):14198-14209. PubMed ID: 30618075
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA Chast promotes cardiac remodeling.
Viereck J; Kumarswamy R; Foinquinos A; Xiao K; Avramopoulos P; Kunz M; Dittrich M; Maetzig T; Zimmer K; Remke J; Just A; Fendrich J; Scherf K; Bolesani E; Schambach A; Weidemann F; Zweigerdt R; de Windt LJ; Engelhardt S; Dandekar T; Batkai S; Thum T
Sci Transl Med; 2016 Feb; 8(326):326ra22. PubMed ID: 26888430
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic CARP promotes angiotensin II- or pressure overload-induced cardiomyocyte hypertrophy through calcineurin accumulation.
Chen C; Shen L; Cao S; Li X; Xuan W; Zhang J; Huang X; Bin J; Xu D; Li G; Kitakaze M; Liao Y
PLoS One; 2014; 9(8):e104040. PubMed ID: 25089522
[TBL] [Abstract][Full Text] [Related]
19. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
[TBL] [Abstract][Full Text] [Related]
20. Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal-Regulating Kinase 1-P38/c-JUN N-Terminal Kinase 1/2 Signaling.
Huang Z; Shu J; Jiang W; Jiang M; Lu Y; Dai H; Xu N; Yuan H; Cai J
J Am Heart Assoc; 2018 Oct; 7(19):e009179. PubMed ID: 30371330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]